NHS National Generic Pharmaceuticals - Wave 15c
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £557,571,000 (£669,085,200 inc. VAT) |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, East Midlands, West Midlands, East of England, South East, South West, London, Yorkshire and the Humber |
| Deadline | 10 Oct 2025 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-05193a |
Awards (150)
This procurement was awarded to 105 suppliers. Values shown are per-award; the notice total is £557,571,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Accord UK Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| AFT Pharma UK shared | £403,702,000 | 13 Jan 2026 | active |
| AGB Pharma shared | £403,702,000 | 13 Jan 2026 | active |
| Aguettant Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Alturix Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Amarox Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Amarox Limited shared | £17,727,000 | 13 Jan 2026 | active |
| AOP Orphan Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Arcadia Pharma Ltd T/A Arcadia Medical shared | £403,702,000 | 13 Jan 2026 | active |
| Ascend Laboratories UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Ascot Laboratories Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Aspen Pharmacare UK Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Aspire Pharma Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Aspire Pharma Limited shared | £37,160,000 | 13 Jan 2026 | active |
| Aventis Pharma ltd t/a Sanofi shared | £403,702,000 | 13 Jan 2026 | active |
| Baxter Healthcare Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Baxter Healthcare Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| B Braun Medical Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Beaumont Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Beaumont Pharma Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Biocon shared | £403,702,000 | 13 Jan 2026 | active |
| Biocon shared | £37,160,000 | 13 Jan 2026 | active |
| Bowmed Ibisqus Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Bowmed Ibisqus Limited shared | £37,160,000 | 13 Jan 2026 | active |
| Brown & Burk UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Brown & Burk UK Ltd shared | £17,727,000 | 13 Jan 2026 | active |
| Celix Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Celix Pharma Ltd shared | £17,727,000 | 13 Jan 2026 | active |
| Chiesi Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Cipla shared | £403,702,000 | 13 Jan 2026 | active |
| Cipla shared | £17,727,000 | 13 Jan 2026 | active |
| Colonis Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Consilient Health Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Consilient Health Ltd shared | £17,727,000 | 13 Jan 2026 | active |
| Crescent Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| CST Pharma Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Day Lewis Medical Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Desitin Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £17,727,000 | 13 Jan 2026 | active |
| Drugsrus Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Ennogen Healthcare Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Eramol (UK) Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Essential Pharma shared | £403,702,000 | 13 Jan 2026 | active |
| Esteve Pharmaceuticals Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Esteve Pharmaceuticals Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Farmak Pharmaceuticals shared | £403,702,000 | 13 Jan 2026 | active |
| Farmak Pharmaceuticals shared | £37,160,000 | 13 Jan 2026 | active |
| Farmak Pharmaceuticals shared | £17,727,000 | 13 Jan 2026 | active |
| Flexipharm Austrading Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Flynn Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Fontus Health Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Fresenius Kabi Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Galen Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Galvany Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Gennisium Pharma shared | £403,702,000 | 13 Jan 2026 | active |
| GlaxoSmithKline UK Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Glenmark Pharmaceuticals Europe Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Glenmark Pharmaceuticals Europe Limited shared | £37,160,000 | 13 Jan 2026 | active |
| G.L. Pharma UK Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Green Park Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Green Park Pharma Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Grindeks Kalceks UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Grindeks Kalceks UK Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Hameln Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Hameln Pharma Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Hikma Pharmaceuticals shared | £403,702,000 | 13 Jan 2026 | active |
| Hikma Pharmaceuticals shared | £37,160,000 | 13 Jan 2026 | active |
| JCSH Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| JCSH Pharma Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Kent Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Kent Pharma Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Leo Pharma shared | £403,702,000 | 13 Jan 2026 | active |
| Lipomed AG shared | £403,702,000 | 13 Jan 2026 | active |
| LogixX Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Lucane Pharma shared | £403,702,000 | 13 Jan 2026 | active |
| Lundbeck Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Macleods Pharma UK Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Macleods Pharma UK Limited shared | £37,160,000 | 13 Jan 2026 | active |
| Macure Pharma ApS shared | £403,702,000 | 13 Jan 2026 | active |
| Martindale Pharma shared | £403,702,000 | 13 Jan 2026 | active |
| Martindale Pharma shared | £37,160,000 | 13 Jan 2026 | active |
| medac Pharma LLP shared | £403,702,000 | 13 Jan 2026 | active |
| Merck Sharpe & Dohme (UK) Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Mercury Pharmaceuticals shared | £403,702,000 | 13 Jan 2026 | active |
| Mercury Pharmaceuticals shared | £37,160,000 | 13 Jan 2026 | active |
| Milpharm Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Milpharm Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Morningside Pharmaceuticals shared | £403,702,000 | 13 Jan 2026 | active |
| Morningside Pharmaceuticals shared | £17,727,000 | 13 Jan 2026 | active |
| MSN Laboratories Europe Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Necessity Supplies Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Neon Healthcare Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Neuraxpharm UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Neuraxpharm UK Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Northumbria Pharma Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Northumbria Pharma Limited shared | £37,160,000 | 13 Jan 2026 | active |
| Novumgen Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Novumgen Limited shared | £17,727,000 | 13 Jan 2026 | active |
| Orifarm UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Otsuka Pharmaceuticals UK Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Panpharma UK Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Pari Medical Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Perennial Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Pfizer Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Pfizer Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Phoenix Lab shared | £403,702,000 | 13 Jan 2026 | active |
| Piramal Critical care Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Reig Jofre UK limited shared | £403,702,000 | 13 Jan 2026 | active |
| Roche Products Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Roche Products Ltd shared | £17,727,000 | 13 Jan 2026 | active |
| Roma Pharmaceuticals Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Rosemont Pharmaceuticals Limited shared | £17,727,000 | 13 Jan 2026 | active |
| ROVI Biotech Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| RPH Pharmaceuticals AB shared | £403,702,000 | 13 Jan 2026 | active |
| RPH Pharmaceuticals AB shared | £17,727,000 | 13 Jan 2026 | active |
| Sandoz Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Sandoz Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Seacross Pharmaceuticals Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Seacross Pharmaceuticals Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Selective Supplies Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Selective Supplies Ltd shared | £17,727,000 | 13 Jan 2026 | active |
| Stirling Anglian Pharmaceuticals Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Strides Pharma UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Sun Pharma UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Sun Pharma UK Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| SVP Pharma Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Synchrony shared | £403,702,000 | 13 Jan 2026 | active |
| Takeda UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Takeda UK Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Teva UK Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Teva UK Limited shared | £37,160,000 | 13 Jan 2026 | active |
| Teva UK Limited shared | £17,727,000 | 13 Jan 2026 | active |
| Thea Pharmaceuticals Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Thornton and Ross Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Tillomed Laboratories ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Torbay Pharmaceuticals shared | £403,702,000 | 13 Jan 2026 | active |
| Torrent Pharma UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Torrent Pharma UK Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Vantage Pharmaceuticals Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| VIATRIS UK HEALTHCARE LIMITED shared | £403,702,000 | 13 Jan 2026 | active |
| VIATRIS UK HEALTHCARE LIMITED shared | £17,727,000 | 13 Jan 2026 | active |
| Waymade PLC shared | £403,702,000 | 13 Jan 2026 | active |
| Wockhardt UK Limited shared | £403,702,000 | 13 Jan 2026 | active |
| Wockhardt UK Limited shared | £37,160,000 | 13 Jan 2026 | active |
| Zentiva Pharma UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Zentiva Pharma UK Ltd shared | £37,160,000 | 13 Jan 2026 | active |
| Zydus Pharmaceuticals UK Ltd shared | £403,702,000 | 13 Jan 2026 | active |
| Zydus Pharmaceuticals UK Ltd shared | £17,727,000 | 13 Jan 2026 | active |
description
NHS National Framework for Generic Pharmaceuticals - Wave 15c
Offer reference number: CM/PHG/23/5699
Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
CM/PHG/23/5699/01 Oral (plus non-parenteral) products CESW/LSNE/NWLN 01/06/2026 to 31/05/2027 (12 months)
CM/PHG/23/5699/02 Hospital only products
DLS: 01/06/2026 to 31/05/2028 (24 months)
DNE: 01/06/2026 to 31/05/2028 (24 months)
CM/PHG/23/5699/03 Hospital only (housekeeping) products DLN/DNW 01/06/2026 to 31/01/2027 (8 months)
DCE/DSW 01/06/2026 to 30/09/2027 (16 months)
documents
- https://www.find-tender.service.gov.uk/Notice/053094-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/054052-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/055409-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/055421-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4714 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4715 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4716 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4717 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4718 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4719 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4720 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4721 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4722 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4723 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4724 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4725 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4726 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4727 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4728 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4729 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5034 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5035 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5036 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5037 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5038 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5039 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5040 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5041 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5043 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5045 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5046 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5048 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5049 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5051 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5053 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5054 , biddingDocuments
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
8 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 20 May 2025 | Pipeline notice (UK1) | Procurement Act 2023 | 023393-2025 |
| 14 Aug 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 048844-2025 |
| 2 Sept 2025 | Tender notice (UK4) | Procurement Act 2023 | 053094-2025 |
| 4 Sept 2025 | Tender notice (UK4) | Procurement Act 2023 | 054052-2025 |
| 10 Sept 2025 | Tender notice (UK4) | Procurement Act 2023 | 055409-2025 |
| 10 Sept 2025 | Tender notice (UK4) | Procurement Act 2023 | 055421-2025 |
| 14 Jan 2026 | Contract award (UK6) | Procurement Act 2023 | 002928-2026 |
| 26 Feb 2026 | Contract details (UK7) | Procurement Act 2023 | 017220-2026 |
more from NHS England
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
- NHS National Framework for Ferric Carboxymaltose injection · £62,633,000 · 21 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.